The landscape of dementia prognosis has progressed dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based checks that could detect Alzheimer's pathology many years before symptoms arise. Even though these technological advances characterize impressive progress in being familiar with neurodegenerative ailments... https://judyv864ufp4.bloguerosa.com/profile